Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

clinical trial recruitment

This page shows the latest clinical trial recruitment news and features for those working in and with pharma, biotech and healthcare.

IQVIA launches new online patient portal

IQVIA launches new online patient portal

The IQVIA Patient Portal focuses on increasing clinical trial patient recruitment, engagement and retention by ensuring transparency and collaboration at all stages of the clinical trial process. ... Clinical trial participants are invited to join the

Latest news

  • Scancell preps phase 2 challenge for melanoma vaccine Scancell preps phase 2 challenge for melanoma vaccine

    trial are in place and the clinical trial centres are ready to start recruitment. ... The drug has already been through a phase 1/2 trial in around 35 patients with melanoma, generating preliminary signs of efficacy as well as an acceptable safety profile

  • NCI head Sharpless named as interim FDA chief NCI head Sharpless named as interim FDA chief

    with efforts to revamp the clinical trial recruitment process and deploy ‘big data’ to interpret trial results.

  • Havas Lynx launch clinical trial recruitment agency Havas Lynx launch clinical trial recruitment agency

    Led by Mark Evans (pictured above), the new offering will address the growing trial patient recruitment challenge, whereby 80% of studies fail to recruit on time according to the agency. ... With Evans at helm, who spent the last six years on Publicis

  • INC Research/InVentiv Health becomes Syneos Health INC Research/InVentiv Health becomes Syneos Health

    More specifically, the company - which becomes the second largest outsourcing provider after IQVIA - combines behavioural insights to accelerate clinical trial recruitment and therapeutic know-how with multi-channel commercial programs to

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    In addition to giving advice on large scale clinical trial design and patient recruitment, KOLs can help pharma tackle critical barriers to success at this point - the need to balance efficacy ... For example, some KOLs may be experts in clinical trial

More from news
Approximately 2 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Biopharma and orphan drugs Biopharma and orphan drugs

    Clinical complications. Given the rarity of orphan diseases, one of the greatest challenges in developing treatments is the timely and adequate recruitment of eligible trial participants. ... Clinical trial design is also more difficult for treatments

  • Healthcare trends 2020 – the biggest shifts changing lives and life sciences Healthcare trends 2020 – the biggest shifts changing lives and life sciences

    New tools and technologies are bringing clinical reporting home or to a third place that looks dramatically different from a major academic center. ... From trial design to open engagement platforms, life sciences leaders are bringing patients to the

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... This has repercussions for both clinical trial

  • Real-world studies Real-world studies

    trial recruitment, support regulatory filings, expand patient access and be used for drug safety surveillance. ... One of the most impactful places that RWD can be used to cut time and costs is in enrolment processes which can consume up to 40% of the

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Jack Brownrigg, Medical Affairs, Rare Disease, Pfizer UK, told us clinical trials with fewer potential participants required more nuanced trial designs. ... At Pfizer, we employ innovative clinical trial designs and participant recruitment strategies to

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Julie Adrian joins inVentiv Health Communications Julie Adrian joins inVentiv Health Communications

    Adrian will oversee the group's advertising, digital, public relations, medical communications, research, market access and clinical trial recruitment agencies across London, Frankfurt, Munich and Paris.

  • Ketchum names new global healthcare practice director

    Her role will involve collaborating with senior counsellors and leaders from Ketchum's other practices and specialty areas, including clinical trial patient recruitment firm MMG, medical education group Inspired Science and

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Quick links

Infographics

Multimedia